198 related articles for article (PubMed ID: 30235249)
41. Mutation in the alpha-cardiac actin gene associated with apical hypertrophic cardiomyopathy, left ventricular non-compaction, and septal defects.
Monserrat L; Hermida-Prieto M; Fernandez X; Rodríguez I; Dumont C; Cazón L; Cuesta MG; Gonzalez-Juanatey C; Peteiro J; Alvarez N; Penas-Lado M; Castro-Beiras A
Eur Heart J; 2007 Aug; 28(16):1953-61. PubMed ID: 17611253
[TBL] [Abstract][Full Text] [Related]
42. The yield of risk stratification for sudden cardiac death in hypertrophic cardiomyopathy myosin-binding protein C gene mutation carriers: focus on predictive screening.
Christiaans I; Birnie E; van Langen IM; van Spaendonck-Zwarts KY; van Tintelen JP; van den Berg MP; Atsma DE; Helderman-van den Enden AT; Pinto YM; Hermans-van Ast JF; Bonsel GJ; Wilde AA
Eur Heart J; 2010 Apr; 31(7):842-8. PubMed ID: 20019025
[TBL] [Abstract][Full Text] [Related]
43. Sudden Unexpected Death of Infantile Dilated Cardiomyopathy with JPH2 and PKD1 Gene Variants.
Miura A; Kondo H; Yamamoto T; Okumura Y; Nishio H
Int Heart J; 2020 Sep; 61(5):1079-1083. PubMed ID: 32879264
[TBL] [Abstract][Full Text] [Related]
44. Prevalence of sarcomere protein gene mutations in preadolescent children with hypertrophic cardiomyopathy.
Kaski JP; Syrris P; Esteban MT; Jenkins S; Pantazis A; Deanfield JE; McKenna WJ; Elliott PM
Circ Cardiovasc Genet; 2009 Oct; 2(5):436-41. PubMed ID: 20031618
[TBL] [Abstract][Full Text] [Related]
45. Microvascular function is selectively impaired in patients with hypertrophic cardiomyopathy and sarcomere myofilament gene mutations.
Olivotto I; Girolami F; Sciagrà R; Ackerman MJ; Sotgia B; Bos JM; Nistri S; Sgalambro A; Grifoni C; Torricelli F; Camici PG; Cecchi F
J Am Coll Cardiol; 2011 Aug; 58(8):839-48. PubMed ID: 21835320
[TBL] [Abstract][Full Text] [Related]
46. Genetics of hypertrophic cardiomyopathy in eastern Finland: few founder mutations with benign or intermediary phenotypes.
Jääskeläinen P; Miettinen R; Kärkkäinen P; Toivonen L; Laakso M; Kuusisto J
Ann Med; 2004; 36(1):23-32. PubMed ID: 15000344
[TBL] [Abstract][Full Text] [Related]
47. Hypertrophic cardiomyopathy: two homozygous cases with "typical" hypertrophic cardiomyopathy and three new mutations in cases with progression to dilated cardiomyopathy.
Nanni L; Pieroni M; Chimenti C; Simionati B; Zimbello R; Maseri A; Frustaci A; Lanfranchi G
Biochem Biophys Res Commun; 2003 Sep; 309(2):391-8. PubMed ID: 12951062
[TBL] [Abstract][Full Text] [Related]
48. α-Galactosidase A Genotype N215S Induces a Specific Cardiac Variant of Fabry Disease.
Oder D; Liu D; Hu K; Üçeyler N; Salinger T; Müntze J; Lorenz K; Kandolf R; Gröne HJ; Sommer C; Ertl G; Wanner C; Nordbeck P
Circ Cardiovasc Genet; 2017 Oct; 10(5):. PubMed ID: 29018006
[TBL] [Abstract][Full Text] [Related]
49. A case of an infant with compound heterozygous mutations for hypertrophic cardiomyopathy producing a phenotype of left ventricular noncompaction.
Haberer K; Buffo-Sequeira I; Chudley AE; Spriggs E; Sergi C
Can J Cardiol; 2014 Oct; 30(10):1249.e1-3. PubMed ID: 25262865
[TBL] [Abstract][Full Text] [Related]
50. [The Val606Met mutation of human beta myosin heavy chain in a Chinese familial hypertrophic cardiomyopathy family].
Yuan JS; Qiao SB; Wang SX; Teng SY; You SJ; Yang WX; Gao RL; Chen JL; Yang YJ
Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Apr; 36(4):313-6. PubMed ID: 19100006
[TBL] [Abstract][Full Text] [Related]
51. Sequence analysis of myozenin 2 in 438 European patients with familial hypertrophic cardiomyopathy.
Posch MG; Thiemann L; Tomasov P; Veselka J; Cardim N; Garcia-Castro M; Coto E; Perrot A; Geier C; Dietz R; Haverkamp W; Ozcelik C
Med Sci Monit; 2008 Jul; 14(7):CR372-4. PubMed ID: 18591919
[TBL] [Abstract][Full Text] [Related]
52. Myosin light chain mutation causes autosomal recessive cardiomyopathy with mid-cavitary hypertrophy and restrictive physiology.
Olson TM; Karst ML; Whitby FG; Driscoll DJ
Circulation; 2002 May; 105(20):2337-40. PubMed ID: 12021217
[TBL] [Abstract][Full Text] [Related]
53. Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy.
Marian AJ; Braunwald E
Circ Res; 2017 Sep; 121(7):749-770. PubMed ID: 28912181
[TBL] [Abstract][Full Text] [Related]
54. Green Tea Catechin Normalizes the Enhanced Ca2+ Sensitivity of Myofilaments Regulated by a Hypertrophic Cardiomyopathy-Associated Mutation in Human Cardiac Troponin I (K206I).
Warren CM; Karam CN; Wolska BM; Kobayashi T; de Tombe PP; Arteaga GM; Bos JM; Ackerman MJ; Solaro RJ
Circ Cardiovasc Genet; 2015 Dec; 8(6):765-73. PubMed ID: 26553696
[TBL] [Abstract][Full Text] [Related]
55. A novel mutation in the cardiac myosin-binding protein C gene is responsible for hypertrophic cardiomyopathy with severe ventricular hypertrophy and sudden death.
Konno T; Shimizu M; Ino H; Fujino N; Uchiyama K; Mabuchi T; Sakata K; Kaneda T; Fujita T; Masuta E; Mabuchi H
Clin Sci (Lond); 2006 Jan; 110(1):125-31. PubMed ID: 16181148
[TBL] [Abstract][Full Text] [Related]
56. Sarcomeric proteins and familial hypertrophic cardiomyopathy: linking mutations in structural proteins to complex cardiovascular phenotypes.
Tardiff JC
Heart Fail Rev; 2005 Sep; 10(3):237-48. PubMed ID: 16416046
[TBL] [Abstract][Full Text] [Related]
57. Danon's disease as a cause of hypertrophic cardiomyopathy: a systematic survey.
Charron P; Villard E; Sébillon P; Laforêt P; Maisonobe T; Duboscq-Bidot L; Romero N; Drouin-Garraud V; Frébourg T; Richard P; Eymard B; Komajda M
Heart; 2004 Aug; 90(8):842-6. PubMed ID: 15253947
[TBL] [Abstract][Full Text] [Related]
58. [Hypertrophic cardiomyopathy].
van Driel B; Asselbergs FW; de Boer RA; van Rossum AC; van Tintelen JP; van der Velden J; Michels M
Ned Tijdschr Geneeskd; 2019 Feb; 163():. PubMed ID: 30730688
[TBL] [Abstract][Full Text] [Related]
59. Variable clinical manifestation of a novel missense mutation in the alpha-tropomyosin (TPM1) gene in familial hypertrophic cardiomyopathy.
Jongbloed RJ; Marcelis CL; Doevendans PA; Schmeitz-Mulkens JM; Van Dockum WG; Geraedts JP; Smeets HJ
J Am Coll Cardiol; 2003 Mar; 41(6):981-6. PubMed ID: 12651045
[TBL] [Abstract][Full Text] [Related]
60. The cardiac beta-myosin heavy chain gene is not the predominant gene for hypertrophic cardiomyopathy in the Finnish population.
Jääskeläinen P; Soranta M; Miettinen R; Saarinen L; Pihlajamäki J; Silvennoinen K; Tikanoja T; Laakso M; Kuusisto J
J Am Coll Cardiol; 1998 Nov; 32(6):1709-16. PubMed ID: 9822100
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
